Eyebright Historical Balance Sheet

688050 Stock

89.09 0.66 0.74%

Trend analysis of Eyebright Medical Technology balance sheet accounts such as Short Long Term Debt Total of 196.6 M, Other Current Liabilities of 130.4 K or Total Current Liabilities of 396.7 M provides information on Eyebright Medical's total assets, liabilities, and equity, which is the actual value of Eyebright Medical to its prevalent stockholders. By breaking down trends over time using Eyebright Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Eyebright Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Eyebright Medical is a good buy for the upcoming year.

Eyebright Medical Inventory

190.42 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Eyebright Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Eyebright Medical at a specified time, usually calculated after every quarter, six months, or one year. Eyebright Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Eyebright Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Eyebright currently owns. An asset can also be divided into two categories, current and non-current.

Eyebright Medical Balance Sheet Chart

At present, Eyebright Medical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 196.6 M, whereas Other Current Liabilities is forecasted to decline to about 130.4 K.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Net Debt Long Term Debt

Total Assets

Total assets refers to the total amount of Eyebright Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Eyebright Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Eyebright Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Eyebright Medical Technology are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Long Term Debt

Long-term debt is a debt that Eyebright Medical has held for over one year. Long-term debt appears on Eyebright Medical Technology balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Eyebright Medical Technology balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most accounts from Eyebright Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Eyebright Medical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024 (projected)
Short and Long Term Debt Total	162.8M	187.2M	196.6M
Total Assets	2.2B	3.1B	3.2B

Short Long Term Debt Total Total Assets

Eyebright Medical balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Short Term Investments	Net Receivables	Net Invested Capital
Total Assets		0.96	0.32	0.93	0.91	0.96	-0.61	0.96	0.87	0.86	0.97	0.74	0.99	0.84	0.92	0.94	0.25	0.88	0.93	0.87	-0.35	0.96	0.91	0.34	0.8	0.96
Short Long Term Debt Total	0.96		0.46	0.86	0.92	0.88	-0.69	0.89	0.76	0.89	0.89	0.75	0.95	0.77	0.85	0.82	0.37	0.9	0.86	0.9	-0.31	0.88	0.89	0.37	0.72	0.96
Other Current Liab	0.32	0.46		0.0	0.56	0.11	-0.58	0.14	-0.15	0.53	0.12	0.59	0.32	0.11	0.1	-0.02	0.57	0.59	0.05	0.65	-0.2	0.08	0.5	0.61	-0.05	0.44
Total Current Liabilities	0.93	0.86	0.0		0.74	0.99	-0.35	0.98	0.98	0.68	0.99	0.58	0.92	0.85	0.98	0.97	0.01	0.68	1.0	0.65	-0.28	0.98	0.74	0.17	0.86	0.87
Total Stockholder Equity	0.91	0.92	0.56	0.74		0.8	-0.74	0.8	0.64	0.96	0.81	0.82	0.9	0.84	0.74	0.76	0.43	0.99	0.74	0.97	-0.35	0.81	0.99	0.45	0.74	0.96
Property Plant And Equipment Net	0.96	0.88	0.11	0.99	0.8		-0.4	1.0	0.96	0.72	1.0	0.66	0.95	0.85	0.98	0.97	0.04	0.74	0.99	0.71	-0.31	0.99	0.79	0.26	0.86	0.9
Net Debt	-0.61	-0.69	-0.58	-0.35	-0.74	-0.4		-0.39	-0.23	-0.87	-0.41	-0.43	-0.6	-0.4	-0.28	-0.43	-0.74	-0.8	-0.32	-0.86	0.38	-0.48	-0.78	-0.13	-0.26	-0.62
Retained Earnings	0.96	0.89	0.14	0.98	0.8	1.0	-0.39		0.96	0.72	1.0	0.72	0.96	0.85	0.98	0.96	0.0	0.75	0.99	0.71	-0.33	0.98	0.79	0.34	0.86	0.91
Accounts Payable	0.87	0.76	-0.15	0.98	0.64	0.96	-0.23	0.96		0.57	0.96	0.53	0.86	0.82	0.95	0.96	-0.14	0.58	0.97	0.53	-0.27	0.95	0.64	0.14	0.87	0.79
Cash	0.86	0.89	0.53	0.68	0.96	0.72	-0.87	0.72	0.57		0.73	0.66	0.84	0.78	0.65	0.71	0.56	0.97	0.67	0.97	-0.4	0.77	0.97	0.25	0.66	0.91
Non Current Assets Total	0.97	0.89	0.12	0.99	0.81	1.0	-0.41	1.0	0.96	0.73		0.68	0.96	0.85	0.98	0.97	0.04	0.75	0.99	0.72	-0.32	0.99	0.8	0.29	0.85	0.91
Non Currrent Assets Other	0.74	0.75	0.59	0.58	0.82	0.66	-0.43	0.72	0.53	0.66	0.68		0.81	0.64	0.64	0.59	0.02	0.78	0.61	0.76	-0.3	0.63	0.76	0.86	0.62	0.81
Cash And Short Term Investments	0.99	0.95	0.32	0.92	0.9	0.95	-0.6	0.96	0.86	0.84	0.96	0.81		0.82	0.9	0.93	0.16	0.87	0.91	0.85	-0.38	0.95	0.89	0.44	0.8	0.96
Common Stock Shares Outstanding	0.84	0.77	0.11	0.85	0.84	0.85	-0.4	0.85	0.82	0.78	0.85	0.64	0.82		0.83	0.84	0.09	0.8	0.84	0.71	-0.32	0.85	0.84	0.2	0.97	0.89
Non Current Liabilities Total	0.92	0.85	0.1	0.98	0.74	0.98	-0.28	0.98	0.95	0.65	0.98	0.64	0.9	0.83		0.93	-0.02	0.68	0.99	0.64	-0.28	0.95	0.72	0.27	0.84	0.87
Inventory	0.94	0.82	-0.02	0.97	0.76	0.97	-0.43	0.96	0.96	0.71	0.97	0.59	0.93	0.84	0.93		0.02	0.72	0.95	0.68	-0.29	0.99	0.78	0.17	0.85	0.84
Other Current Assets	0.25	0.37	0.57	0.01	0.43	0.04	-0.74	0.0	-0.14	0.56	0.04	0.02	0.16	0.09	-0.02	0.02		0.51	0.0	0.6	-0.03	0.08	0.48	-0.17	-0.1	0.29
Other Stockholder Equity	0.88	0.9	0.59	0.68	0.99	0.74	-0.8	0.75	0.58	0.97	0.75	0.78	0.87	0.8	0.68	0.72	0.51		0.69	0.99	-0.34	0.76	0.99	0.41	0.69	0.93
Total Liab	0.93	0.86	0.05	1.0	0.74	0.99	-0.32	0.99	0.97	0.67	0.99	0.61	0.91	0.84	0.99	0.95	0.0	0.69		0.65	-0.28	0.97	0.73	0.22	0.86	0.87
Total Current Assets	0.87	0.9	0.65	0.65	0.97	0.71	-0.86	0.71	0.53	0.97	0.72	0.76	0.85	0.71	0.64	0.68	0.6	0.99	0.65		-0.34	0.73	0.97	0.41	0.6	0.91
Short Term Debt	-0.35	-0.31	-0.2	-0.28	-0.35	-0.31	0.38	-0.33	-0.27	-0.4	-0.32	-0.3	-0.38	-0.32	-0.28	-0.29	-0.03	-0.34	-0.28	-0.34		-0.33	-0.33	-0.15	-0.26	-0.37
Intangible Assets	0.96	0.88	0.08	0.98	0.81	0.99	-0.48	0.98	0.95	0.77	0.99	0.63	0.95	0.85	0.95	0.99	0.08	0.76	0.97	0.73	-0.33		0.81	0.21	0.84	0.89
Common Stock	0.91	0.89	0.5	0.74	0.99	0.79	-0.78	0.79	0.64	0.97	0.8	0.76	0.89	0.84	0.72	0.78	0.48	0.99	0.73	0.97	-0.33	0.81		0.37	0.74	0.94
Short Term Investments	0.34	0.37	0.61	0.17	0.45	0.26	-0.13	0.34	0.14	0.25	0.29	0.86	0.44	0.2	0.27	0.17	-0.17	0.41	0.22	0.41	-0.15	0.21	0.37		0.22	0.42
Net Receivables	0.8	0.72	-0.05	0.86	0.74	0.86	-0.26	0.86	0.87	0.66	0.85	0.62	0.8	0.97	0.84	0.85	-0.1	0.69	0.86	0.6	-0.26	0.84	0.74	0.22		0.83
Net Invested Capital	0.96	0.96	0.44	0.87	0.96	0.9	-0.62	0.91	0.79	0.91	0.91	0.81	0.96	0.89	0.87	0.84	0.29	0.93	0.87	0.91	-0.37	0.89	0.94	0.42	0.83

Click cells to compare fundamentals

Eyebright Medical Account Relationship Matchups

Eyebright Medical balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	685.8M	1.6B	2.0B	2.2B	3.1B	3.2B
Short Long Term Debt Total	7.7M	894.5K	154.8M	162.8M	187.2M	196.6M
Other Current Liab	21.9M	74.9M	133.9M	133.9M	137.3K	130.4K
Total Current Liabilities	23.1M	77.1M	139.4M	147.7M	377.8M	396.7M
Total Stockholder Equity	617.6M	1.5B	1.7B	1.9B	2.1B	1.2B
Property Plant And Equipment Net	183.1M	267.1M	558.7M	674.2M	1.3B	1.3B
Net Debt	(195.4M)	(536.8M)	(318.0M)	(192.1M)	(172.9M)	(181.5M)
Retained Earnings	2.5M	90.0M	213.5M	391.4M	647.2M	679.5M
Accounts Payable	280.9K	2.2M	5.6M	13.9M	49.0M	51.5M
Cash	196.3M	536.8M	472.9M	354.9M	536.7M	308.0M
Non Current Assets Total	351.3M	492.4M	928.9M	1.2B	2.0B	2.1B
Non Currrent Assets Other	42.2M	87.2M	86.2M	317.6M	170.0M	107.0M
Cash And Short Term Investments	196.3M	537.1M	473.4M	836.9M	962.4M	1.0B
Common Stock Shares Outstanding	78.5M	89.4M	105.1M	105.3M	189.5M	106.7M
Liabilities And Stockholders Equity	685.8M	1.6B	2.0B	2.2B	2.6B	2.7B
Non Current Liabilities Total	15.1M	13.8M	168.0M	176.6M	328.1M	344.5M
Inventory	60.8M	59.1M	56.0M	78.8M	181.4M	190.4M
Other Current Assets	12.9M	466.6M	504.1M	11.3M	36.5M	34.6M
Other Stockholder Equity	536.2M	1.3B	1.4B	1.4B	1.6B	845.9M
Total Liab	38.3M	90.9M	307.5M	324.3M	705.9M	741.1M
Total Current Assets	334.5M	1.1B	1.1B	1.1B	1.0B	718.5M
Intangible Assets	100.6M	112.9M	127.8M	140.3M	252.2M	264.8M
Common Stock	78.8M	78.8M	105.1M	105.2M	121.0M	93.5M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Eyebright Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Eyebright Historical Balance Sheet

Eyebright Medical Inventory

190.42 Million

About Eyebright Balance Sheet Analysis

Eyebright Medical Balance Sheet Chart

Total Assets

Total Current Liabilities

Net Debt

Long Term Debt

Eyebright Medical balance sheet Correlations

Eyebright Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Eyebright Medical balance sheet Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Eyebright Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Retained Earnings	+ 1.0	Property Plant And Equipment Net
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Non Current Assets Total	+ 1.0	Retained Earnings
Cash And Short Term Investments	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Current Liabilities

Cash	- 0.87	Net Debt
Total Current Assets	- 0.86	Net Debt
Other Stockholder Equity	- 0.8	Net Debt
Common Stock	- 0.78	Net Debt
Other Current Assets	- 0.74	Net Debt
Net Debt	- 0.74	Total Stockholder Equity